SCHEMBL7909528

SCHEMBL7909528

COC(=O)O/N=C(/C)NCCCC[C@H](N)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 7/20 0.48
NOS1 P29475 6/20 0.48
NOS3 P29474 4/20 0.48
CYP1A2 P05177 2/20 0.48
TSHR P16473 2/20 0.48
CYP3A4 P08684 1/20 0.48
BLM P54132 1/20 0.47
CYP2C19 P33261 3/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
DDAH1 O94760 6/20 0.44
OTC P00480 1/20 0.41
GSR P00390 1/20 0.41
GLA P06280 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41
THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224528 1.00 NOS2 (0.48) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7226879 0.90 NOS2 (0.49) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7911885 0.90 NOS2 (0.49) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7911329 0.86 NOS2 (0.46) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7226863 0.86 NOS2 (0.46) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7908719 0.85 NOS2 (0.46) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7232942 0.85 NOS2 (0.46) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7908800 0.81 TNF (0.41) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7225511 0.81 TNF (0.41) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7915399 0.80 NOS2 (0.50) NOS2NOS1NOS3CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO claimed